Cart is empty A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for evaluating new therapies.
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for evaluating new therapies.
Leave A Comment